Providing balance in ASCO clinical practice guidelines: CYP2D6 genotyping and tamoxifen efficacy

Matthew Philip Goetz, Mark Ratain, James N. Ingle

Research output: Contribution to journalLetter

4 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)3944-3945
Number of pages2
JournalJournal of Clinical Oncology
Volume34
Issue number32
DOIs
StatePublished - Nov 10 2016

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Providing balance in ASCO clinical practice guidelines : CYP2D6 genotyping and tamoxifen efficacy. / Goetz, Matthew Philip; Ratain, Mark; Ingle, James N.

In: Journal of Clinical Oncology, Vol. 34, No. 32, 10.11.2016, p. 3944-3945.

Research output: Contribution to journalLetter

@article{788691824afe4647873ab4c414e2803a,
title = "Providing balance in ASCO clinical practice guidelines: CYP2D6 genotyping and tamoxifen efficacy",
author = "Goetz, {Matthew Philip} and Mark Ratain and Ingle, {James N.}",
year = "2016",
month = "11",
day = "10",
doi = "10.1200/JCO.2016.68.5214",
language = "English (US)",
volume = "34",
pages = "3944--3945",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "32",

}

TY - JOUR

T1 - Providing balance in ASCO clinical practice guidelines

T2 - CYP2D6 genotyping and tamoxifen efficacy

AU - Goetz, Matthew Philip

AU - Ratain, Mark

AU - Ingle, James N.

PY - 2016/11/10

Y1 - 2016/11/10

UR - http://www.scopus.com/inward/record.url?scp=84994460707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994460707&partnerID=8YFLogxK

U2 - 10.1200/JCO.2016.68.5214

DO - 10.1200/JCO.2016.68.5214

M3 - Letter

C2 - 27551126

AN - SCOPUS:84994460707

VL - 34

SP - 3944

EP - 3945

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 32

ER -